Uniplan Investment Counsel, Inc. Royalty Pharma PLC Transaction History
Uniplan Investment Counsel, Inc.
- $961 Million
- Q1 2025
A detailed history of Uniplan Investment Counsel, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Uniplan Investment Counsel, Inc. holds 51,838 shares of RPRX stock, worth $1.7 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
51,838
Previous 39,934
29.81%
Holding current value
$1.7 Million
Previous $1.02 Million
58.45%
% of portfolio
0.17%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
483Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.35 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$756 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$440 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$399 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...